Merck & Company is driving forward in its quest to develop a premier immuno-oncology pipeline. The company plunked down $394 million to acquire Australia-based Viralytics Ltd and its oncolytic immunotherapy treatments.
Nursing facilities and home- and community-based services are important for individuals' well-being and can often prevent the need for acute inpatient hospitalizations, which is why it’s important to choose suitable medical hospital beds. Ddu, the leading global pharmaceutical & medical device B2B online platform, now offers you some suggestions on how to choose your medical hospital beds.
According to a new market research report by BIS Research, the global surgical robotics market is expected to reach a value of $12.6 billion by the year 2025.
Quite a number of people develop nearsightedness or farsightedness during their lifetimes. "Nanodrops," a new eye drop developed by Israeli ophthalmologists, has successfully fixed corneas in pig eyes, and could potentially do the same for people.
Sepsis, a potentially life-threatening complication of infection, is currently treated with antibiotics which kill the infection-causing bacteria. But research out of the University of Pennsylvania spotlights an alternative approach: Delivering certain gut microbes to mice boosted antibody levels in mice, protecting them against the widespread inflammation that can lead to sepsis.
US regulators are undertaking a speedy review of Shire’s lanadelumab (SHP643) for the prevention of angioedema attacks in patients 12 years and older with hereditary angioedema (HAE).
Treatment with Novartis’ Ultibro Breezhaler significantly boosted lung and cardiac function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation, trial findings show.
The mobile health industry is exploding, and it’s not just because more Americans than ever own smart devices. Providers and patients alike are realizing real value in mobile health technology as advancements ease the path to greater efficiency and lower costs.
Two Indian engineers have invented a portable photo-therapy device which allows parents treat jaundice within the comfort of their homes. The Neolight system is based on blue light-emitting diodes (LED) that can be used at home. It works on solar as well as battery power. The photo device can produce different wavelengths of light for the treatment of varying severities of infant jaundice.
The national average colorectal screening rate is 39 percent but at Albany Area Primary Health Care it's 60 percent.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.